NeonMind Biosciences Price Prediction

NMDBFDelisted Stock  USD 0.50  0.00  0.00%   
As of 22nd of December 2024 the relative strength index (rsi) of NeonMind Biosciences' share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of NeonMind Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of NeonMind Biosciences and does not consider all of the tangible or intangible factors available from NeonMind Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with NeonMind Biosciences, which may create opportunities for some arbitrage if properly timed.
Using NeonMind Biosciences hype-based prediction, you can estimate the value of NeonMind Biosciences from the perspective of NeonMind Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in NeonMind Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying NeonMind because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

NeonMind Biosciences after-hype prediction price

    
  USD 0.5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Intrinsic
Valuation
LowRealHigh
0.350.350.55
Details
Naive
Forecast
LowNextHigh
0.570.570.57
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
00.360.71
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NeonMind Biosciences. Your research has to be compared to or analyzed against NeonMind Biosciences' peers to derive any actionable benefits. When done correctly, NeonMind Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NeonMind Biosciences.

NeonMind Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of NeonMind Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NeonMind Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of NeonMind Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

NeonMind Biosciences Estimiated After-Hype Price Volatility

In the context of predicting NeonMind Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NeonMind Biosciences' historical news coverage. NeonMind Biosciences' after-hype downside and upside margins for the prediction period are 0.50 and 0.50, respectively. We have considered NeonMind Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.50
0.50
After-hype Price
0.50
Upside
NeonMind Biosciences is very steady at this time. Analysis and calculation of next after-hype price of NeonMind Biosciences is based on 3 months time horizon.

NeonMind Biosciences Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as NeonMind Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeonMind Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NeonMind Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
8 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.50
0.50
0.00 
0.00  
Notes

NeonMind Biosciences Hype Timeline

NeonMind Biosciences is now traded for 0.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NeonMind is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on NeonMind Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.50. The company recorded a loss per share of 0.14. NeonMind Biosciences had not issued any dividends in recent years. The entity had 1:4 split on the 18th of April 2022. Assuming the 90 days horizon the next forecasted press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

NeonMind Biosciences Related Hype Analysis

Having access to credible news sources related to NeonMind Biosciences' direct competition is more important than ever and may enhance your ability to predict NeonMind Biosciences' future price movements. Getting to know how NeonMind Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NeonMind Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
FTHWFField Trip Health 0.00 0 per month 0.00 (0.11) 0.00 (7.50) 30.40 
AGNPFAlgernon Pharmaceuticals 0.00 0 per month 7.79 (0) 16.58 (15.66) 55.53 
AWKNFAwakn Life Sciences 0.00 0 per month 7.30  0.05  18.00 (10.59) 43.08 
KAKineta Inc 0.20 3 per month 0.00 (0.03) 10.45 (10.00) 41.46 
ATAIATAI Life Sciences(0.02)6 per month 4.24  0  11.01 (7.53) 28.12 
MNMDMind Medicine(0.52)7 per month 3.80  0.06  9.76 (7.51) 24.75 
SEELSeelos Therapeutics 0.00 0 per month 0.00 (0.26) 13.18 (25.00) 104.99 
GHRSGH Research PLC 1.36 7 per month 0.00 (0.02) 8.59 (9.52) 26.47 
FRLNFreeline Therapeutics Holdings(0.58)1 per month 0.00 (0.01) 14.23 (13.11) 72.38 
CYBNCybin Inc(2.76)5 per month 4.05  0.05  9.19 (7.40) 24.94 
XFORX4 Pharmaceuticals(0.22)10 per month 10.68  0.04  13.85 (13.51) 67.48 
GRTXGalera Therapeutics 0.00 0 per month 0.00 (0.01) 7.31 (5.84) 18.16 
TERNTerns Pharmaceuticals(0.05)10 per month 0.00 (0.19) 5.17 (6.80) 26.61 
DAWNDay One Biopharmaceuticals(0.59)10 per month 0.00 (0.08) 3.21 (3.69) 11.05 
HOOKHookipa Pharma(0.28)7 per month 0.00 (0.31) 6.85 (6.67) 22.36 
FBIOFortress Biotech 0.13 10 per month 4.52 (0.0005) 9.52 (5.78) 22.17 

NeonMind Biosciences Additional Predictive Modules

Most predictive techniques to examine NeonMind price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeonMind using various technical indicators. When you analyze NeonMind charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About NeonMind Biosciences Predictive Indicators

The successful prediction of NeonMind Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NeonMind Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NeonMind Biosciences based on analysis of NeonMind Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NeonMind Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeonMind Biosciences's related companies.

Story Coverage note for NeonMind Biosciences

The number of cover stories for NeonMind Biosciences depends on current market conditions and NeonMind Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NeonMind Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NeonMind Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

NeonMind Biosciences Short Properties

NeonMind Biosciences' future price predictability will typically decrease when NeonMind Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NeonMind Biosciences often depends not only on the future outlook of the potential NeonMind Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NeonMind Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding31.7 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in NeonMind Pink Sheet

If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios